Loading...
Header Logo
Keywords
Last Name
Institution

Ms Catherine Goodman

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Campbell OM, Benova L, Macleod D, Goodman C, Footman K, Pereira AL, Lynch CA. Who, What, Where: an analysis of private sector family planning provision in 57 low- and middle-income countries. Trop Med Int Health. 2015 Dec; 20(12):1639-56. PMID: 26412363.
      View in: PubMed
    2. Bruxvoort K, Festo C, Cairns M, Kalolella A, Mayaya F, Kachur SP, Schellenberg D, Goodman C. Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device. PLoS One. 2015; 10(7):e0134275. PMID: 26214848; PMCID: PMC4516331.
    3. Patouillard E, Hanson K, Kleinschmidt I, Palafox B, Tougher S, Pok S, O'Connell K, Goodman C. Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia. Malar J. 2015 May 30; 14:224. PMID: 26024880; PMCID: PMC4462075.
    4. Bruxvoort K, Kalolella A, Cairns M, Festo C, Kenani M, Lyaruu P, Kachur SP, Schellenberg D, Goodman C. Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy? Malar J. 2015 Feb 19; 14:87. PMID: 25889767; PMCID: PMC4340668.
    5. Wafula F, Abuya T, Amin A, Goodman C. The policy-practice gap: describing discordances between regulation on paper and real-life practices among specialized drug shops in Kenya. BMC Health Serv Res. 2014 Sep 16; 14:394. PMID: 25227916; PMCID: PMC4175572.
    6. Tougher S, Mann AG. Improving access to malaria medicine through private-sector subsidies in seven African countries. Health Aff (Millwood). 2014 Sep; 33(9):1576-85. PMID: 25201662.
      View in: PubMed
    7. Bruxvoort K, Festo C, Kalolella A, Cairns M, Lyaruu P, Kenani M, Kachur SP, Goodman C, Schellenberg D. Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence. Am J Trop Med Hyg. 2014 Oct; 91(4):844-53. PMID: 25002300; PMCID: PMC4183415.
    8. Reynolds J, DiLiberto D, Mangham-Jefferies L, Ansah EK, Lal S, Mbakilwa H, Bruxvoort K, Webster J, Vestergaard LS, Yeung S, Leslie T, Hutchinson E, Reyburn H, Lalloo DG, Schellenberg D, Cundill B, Staedke SG, Wiseman V, Goodman C, Chandler CI. The practice of 'doing' evaluation: lessons learned from nine complex intervention trials in action. Implement Sci. 2014 Jun 17; 9:75. PMID: 24935096; PMCID: PMC4079170.
    9. Opwora A, Waweru E, Toda M, Noor A, Edwards T, Fegan G, Molyneux S, Goodman C. Implementation of patient charges at primary care facilities in Kenya: implications of low adherence to user fee policy for users and facility revenue. Health Policy Plan. 2015 May; 30(4):508-17. PMID: 24837638; PMCID: PMC4385819.
    10. Thomson R, Festo C, Johanes B, Kalolella A, Bruxvoort K, Nchimbi H, Tougher S, Cairns M, Taylor M, Kleinschmidt I, Ye Y, Mann A, Ren R, Willey B, Arnold F, Hanson K, Kachur SP, Goodman C. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria. PLoS One. 2014; 9(5):e95607. PMID: 24816649; PMCID: PMC4015933.
    11. Briggs MA, Kalolella A, Bruxvoort K, Wiegand R, Lopez G, Festo C, Lyaruu P, Kenani M, Abdulla S, Goodman C, Kachur SP. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies. PLoS One. 2014; 9(4):e94074. PMID: 24732258; PMCID: PMC3986050.
    12. Palafox B, Patouillard E, Tougher S, Goodman C, Hanson K, Kleinschmidt I, Rueda ST, Kiefer S, O'Connell KA, Zinsou C, Phok S, Akulayi L, Arogundade E, Buyungo P, Mpasela F, Chavasse D. Understanding private sector antimalarial distribution chains: a cross-sectional mixed methods study in six malaria-endemic countries. PLoS One. 2014; 9(4):e93763. PMID: 24699934; PMCID: PMC3974780.
    13. Willey BA, Tougher S, Ye Y. Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention. Malar J. 2014 Feb 04; 13:46. PMID: 24495691; PMCID: PMC3924415.
    14. Bruxvoort K, Goodman C, Kachur SP, Schellenberg D. How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs. PLoS One. 2014; 9(1):e84555. PMID: 24465418; PMCID: PMC3896377.
    15. Waweru E, Opwora A, Toda M, Fegan G, Edwards T, Goodman C, Molyneux S. Are Health Facility Management Committees in Kenya ready to implement financial management tasks: findings from a nationally representative survey. BMC Health Serv Res. 2013 Oct 10; 13:404. PMID: 24107094; PMCID: PMC3853226.
    16. Patouillard E, Kleinschmidt I, Hanson K, Pok S, Palafox B, Tougher S, O'Connell K, Goodman C. Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys. Malar J. 2013 Sep 05; 12:311. PMID: 24010526; PMCID: PMC3848597.
    17. Wafula F, Molyneux C, Mackintosh M, Goodman C. Protecting the public or setting the bar too high? Understanding the causes and consequences of regulatory actions of front-line regulators and specialized drug shop operators in Kenya. Soc Sci Med. 2013 Nov; 97:220-7. PMID: 24016728; PMCID: PMC3898801.
    18. Bruxvoort K, Kalolella A, Nchimbi H, Festo C, Taylor M, Thomson R, Cairns M, Thwing J, Kleinschmidt I, Goodman C, Kachur SP. Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania. Trop Med Int Health. 2013 Oct; 18(10):1269-82. PMID: 23937722; PMCID: PMC4282336.
    19. Njau JD, Kabanywanyi AM, Goodman CA, Macarthur JR, Kapella BK, Gimnig JE, Kahigwa E, Bloland PB, Abdulla SM, Kachur SP. Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural Tanzania. Malar J. 2013 Jul 11; 12:236. PMID: 23844934; PMCID: PMC3710484.
    20. Dingle A, Powell-Jackson T, Goodman C. A decade of improvements in equity of access to reproductive and maternal health services in Cambodia, 2000-2010. Int J Equity Health. 2013 Jul 09; 12:51. PMID: 23837577; PMCID: PMC3723953.
    21. Tougher S, Ye Y, Goodman C, Arnold F, Hanson K. Evaluation of the Affordable Medicines Facility--malaria - Authors' reply. Lancet. 2013 Mar 30; 381(9872):1095-6. PMID: 23540850.
      View in: PubMed
    22. Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, Fegan GW, Todd JE, Snow RW, Goodman CA. The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial. Malar J. 2013 Mar 01; 12:81. PMID: 23452547; PMCID: PMC3614520.
    23. O'Connell KA, Poyer S, Solomon T, Munroe E, Patouillard E, Njogu J, Evance I, Hanson K, Shewchuk T, Goodman C. Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J. 2013 Feb 05; 12:52. PMID: 23383972; PMCID: PMC3599752.
    24. Kedenge SV, Kangwana BP, Waweru EW, Nyandigisi AJ, Pandit J, Brooker SJ, Snow RW, Goodman CA. Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya. PLoS One. 2013; 8(1):e54371. PMID: 23342143; PMCID: PMC3544761.
    25. Toda M, Opwora A, Waweru E, Noor A, Edwards T, Fegan G, Molyneux C, Goodman C. Analyzing the equity of public primary care provision in Kenya: variation in facility characteristics by local poverty level. Int J Equity Health. 2012 Dec 13; 11:75. PMID: 23236992; PMCID: PMC3544635.
    26. Goodman CD, Useglio M, Peirú S, Labadie GR, McFadden GI, Rodríguez E, Gramajo H. Chemobiosynthesis of new antimalarial macrolides. Antimicrob Agents Chemother. 2013 Feb; 57(2):907-13. PMID: 23208707; PMCID: PMC3553691.
    27. Tougher S. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet. 2012 Dec 01; 380(9857):1916-26. PMID: 23122217.
      View in: PubMed
    28. Smith R, Lagarde M, Blaauw D, Goodman C, English M, Mullei K, Pagaiya N, Tangcharoensathien V, Erasmus E, Hanson K. Appealing to altruism: an alternative strategy to address the health workforce crisis in developing countries? J Public Health (Oxf). 2013 Mar; 35(1):164-70. PMID: 22915772; PMCID: PMC3856341.
    29. Wafula FN, Miriti EM, Goodman CA. Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res. 2012 Jul 27; 12:223. PMID: 22838649; PMCID: PMC3520114.
    30. Khatib RA, Skarbinski J, Njau JD, Goodman CA, Elling BF, Kahigwa E, Roberts JM, MacArthur JR, Gutman JR, Kabanywanyi AM, Smith EE, Somi MF, Lyimo T, Mwita A, Genton B, Tanner M, Mills A, Mshinda H, Bloland PB, Abdulla SM, Kachur SP. Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study. Malar J. 2012 Apr 30; 11:140. PMID: 22545573; PMCID: PMC3528415.
    31. Molyneux S, Atela M, Angwenyi V, Goodman C. Community accountability at peripheral health facilities: a review of the empirical literature and development of a conceptual framework. Health Policy Plan. 2012 Oct; 27(7):541-54. PMID: 22279082; PMCID: PMC3465752.
    32. O'Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J. 2011 Oct 31; 10:326. PMID: 22039838; PMCID: PMC3227612.
    33. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, Munroe E, Chapman S, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Shewchuk T, Chavasse D, O'Connell KA. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J. 2011 Oct 31; 10:327. PMID: 22039892; PMCID: PMC3223147.
    34. Shewchuk T, O'Connell KA, Goodman C, Hanson K, Chapman S, Chavasse D. The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J. 2011 Oct 31; 10:325. PMID: 22039780; PMCID: PMC3217875.
    35. Goodman C, Opwora A, Kabare M, Molyneux S. Health facility committees and facility management - exploring the nature and depth of their roles in Coast Province, Kenya. BMC Health Serv Res. 2011 Sep 22; 11:229. PMID: 21936958; PMCID: PMC3197493.
    36. Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, Fegan GW, Todd JE, Brooker S, Snow RW, Goodman CA. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial. PLoS Med. 2011 May; 8(5):e1000437. PMID: 21655317; PMCID: PMC3104978.
    37. Mushi HP, Mullei K, Macha J, Wafula F, Borghi J, Goodman C, Gilson L. The challenges of achieving high training coverage for IMCI: case studies from Kenya and Tanzania. Health Policy Plan. 2011 Sep; 26(5):395-404. PMID: 21047808; PMCID: PMC3157918.
    38. Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, Bishop D, Odhiambo M, Ipuge Y, Ward L, Mwita A, Goodman C. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv Res. 2010 Jul 02; 10 Suppl 1:S6. PMID: 20594372; PMCID: PMC2895750.
    39. Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Malar J. 2010 Jun 15; 9:164. PMID: 20550654; PMCID: PMC2910018.
    40. Wafula FN, Goodman CA. Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature. Int J Qual Health Care. 2010 Aug; 22(4):316-23. PMID: 20430823; PMCID: PMC2908156.
    41. Opwora A, Kabare M, Molyneux S, Goodman C. Direct facility funding as a response to user fee reduction: implementation and perceived impact among Kenyan health centres and dispensaries. Health Policy Plan. 2010 Sep; 25(5):406-18. PMID: 20211967; PMCID: PMC2929466.
    42. Patouillard E, Hanson KG, Goodman CA. Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malar J. 2010 Feb 11; 9:50. PMID: 20149246; PMCID: PMC2836367.
    43. Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One. 2009 Sep 02; 4(9):e6857. PMID: 19724644; PMCID: PMC2730578.
    44. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A. Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Health Econ. 2009 Jun; 18(6):727-42. PMID: 19301420; PMCID: PMC2689512.
    45. Chuma J, Musimbi J, Okungu V, Goodman C, Molyneux C. Reducing user fees for primary health care in Kenya: Policy on paper or policy in practice? Int J Equity Health. 2009 May 08; 8:15. PMID: 19422726; PMCID: PMC2683851.
    46. Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am J Trop Med Hyg. 2009 May; 80(5):737-8. PMID: 19407116; PMCID: PMC2679204.
    47. Hanson KG, Gilson L, Goodman C, Mills A. The fallacy of competing interest statements: no shortcut to rigour in research. J R Soc Med. 2009 Apr; 102(4):126. PMID: 19349497; PMCID: PMC2666061.
    48. Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJ, Kokwaro GO, Lindegårdh N, Lukulay P, White LJ, Day NP, Green MD, White NJ. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009 Mar 24; 6(3):e52. PMID: 19320538; PMCID: PMC2659710.
    49. English M, Reyburn H, Goodman C, Snow RW. Abandoning presumptive antimalarial treatment for febrile children aged less than five years--a case of running before we can walk? PLoS Med. 2009 Jan 06; 6(1):e1000015. PMID: 19127977.
      View in: PubMed
    50. Shillcutt SD, Walker DG, Goodman CA, Mills AJ. Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics. 2009; 27(11):903-17. PMID: 19888791; PMCID: PMC2810517.
    51. Yukich JO, Lengeler C, Tediosi F, Brown N, Mulligan JA, Chavasse D, Stevens W, Justino J, Conteh L, Maharaj R, Erskine M, Mueller DH, Wiseman V, Ghebremeskel T, Zerom M, Goodman C, McGuire D, Urrutia JM, Sakho F, Hanson K, Sharp B. Costs and consequences of large-scale vector control for malaria. Malar J. 2008 Dec 17; 7:258. PMID: 19091114; PMCID: PMC2625363.
    52. Hanson K, Gilson L, Goodman C, Mills A, Smith R, Feachem R, Feachem NS, Koehlmoos TP, Kinlaw H. Is private health care the answer to the health problems of the world's poor? PLoS Med. 2008 Nov 25; 5(11):e233. PMID: 19067483; PMCID: PMC2586358.
    53. Kaur H, Goodman C, Thompson E, Thompson KA, Masanja I, Kachur SP, Abdulla S. A nationwide survey of the quality of antimalarials in retail outlets in Tanzania. PLoS One. 2008; 3(10):e3403. PMID: 18923672; PMCID: PMC2565501.
    54. Wasunna B, Zurovac D, Goodman CA, Snow RW. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J. 2008 Feb 05; 7:29. PMID: 18252000; PMCID: PMC2266770.
    55. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills A. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ. 2008 Feb; 86(2):101-10. PMID: 18297164; PMCID: PMC2647374.
    56. Njau JD, Goodman CA, Kachur SP, Mulligan J, Munkondya JS, McHomvu N, Abdulla S, Bloland P, Mills A. The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. Malar J. 2008 Jan 07; 7:4. PMID: 18179716; PMCID: PMC2249587.
    57. Goodman C, Brieger W, Unwin A, Mills A, Meek S, Greer G. Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg. 2007 Dec; 77(6 Suppl):203-18. PMID: 18165494; PMCID: PMC2657822.
    58. Patouillard E, Goodman CA, Hanson KG, Mills AJ. Can working with the private for-profit sector improve utilization of quality health services by the poor? A systematic review of the literature. Int J Equity Health. 2007 Nov 07; 6:17. PMID: 17988396; PMCID: PMC2186328.
    59. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A. Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health Policy Plan. 2007 Nov; 22(6):393-403. PMID: 17921151; PMCID: PMC2657823.
    60. Hetzel MW, Msechu JJ, Goodman C, Lengeler C, Obrist B, Kachur SP, Makemba A, Nathan R, Schulze A, Mshinda H. Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malar J. 2006 Nov 14; 5:109. PMID: 17105662; PMCID: PMC1654173.
    61. Goodman CA, Mutemi WM, Baya EK, Willetts A, Marsh V. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya. Health Policy Plan. 2006 Jul; 21(4):275-88. PMID: 16682433.
      View in: PubMed
    62. Patrick Kachur S, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, Causer LM, Mkikima S, Abdulla S, Bloland PB. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health. 2006 Apr; 11(4):441-51. PMID: 16553927.
      View in: PubMed
    63. Kachur SP, Black C, Abdulla S, Goodman C. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malar J. 2006 Mar 29; 5:25. PMID: 16569252; PMCID: PMC1444918.
    64. Coleman PG, Morel C, Shillcutt S, Goodman C, Mills AJ. A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):196-204. PMID: 15331838.
      View in: PubMed
    65. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health. 2004 Jun; 9(6):655-63. PMID: 15189455.
      View in: PubMed
    66. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy. 2003 Jan; 63(1):17-36. PMID: 12468115.
      View in: PubMed
    67. Goodman CA, Coleman PG, Mills AJ. Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs. Health Econ. 2001 Dec; 10(8):731-49. PMID: 11747054.
      View in: PubMed
    68. Goodman CA, Coleman PG, Mills AJ. The cost-effectiveness of antenatal malaria prevention in sub-Saharan Africa. Am J Trop Med Hyg. 2001 Jan-Feb; 64(1-2 Suppl):45-56. PMID: 11425177.
      View in: PubMed
    69. Goodman CA, Mills AJ. The evidence base on the cost-effectiveness of malaria control measures in Africa. Health Policy Plan. 1999 Dec; 14(4):301-12. PMID: 10787646.
      View in: PubMed
    70. Goodman CA, Coleman PG, Mills AJ. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet. 1999 Jul 31; 354(9176):378-85. PMID: 10437867.
      View in: PubMed
    Goodman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description